Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06505187

Celecoxib for ENT Pain Management

Led by University of Wisconsin, Madison · Updated on 2025-12-03

84

Participants Needed

1

Research Sites

78 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to find out whether pain can be managed after an operation with celecoxib instead of oxycodone. The main question it aims to answer is if use of celecoxib plus Tylenol reduces the need for oxycodone. Researchers will compare the combination of celecoxib and Tylenol to a placebo to find out whether celecoxib works to manage pain. Participants will: * Take celecoxib, or a placebo, plus Tylenol with opioids as needed * Keep a diary of their pain between visits * Complete questionnaires

CONDITIONS

Official Title

Celecoxib for ENT Pain Management

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Ability to understand and willing to sign informed consent
  • Willing to comply with all study procedures and be available for the duration
  • Ability to take oral medication
  • Undergoing superficial parotidectomy
  • At least 18 years of age
  • Adequate organ function as shown by standard lab tests (blood count and chemistry)
Not Eligible

You will not qualify if you...

  • History of contraindications to NSAIDs, including severe heart failure, recent coronary artery bypass graft within 14 days, arrhythmias, significant coronary artery disease, cardiomyopathy, severe liver impairment, peptic ulcer disease or gastrointestinal bleeding
  • Use of anticoagulation other than prophylactic aspirin
  • History of uncontrolled high blood pressure or stroke
  • Allergy to celecoxib or sulfa drugs
  • Concurrent use of cytochrome CYP2C9 potentiators or inhibitors
  • Use of investigational drugs, biologics, or devices within 30 days prior to randomization
  • Pregnancy, breastfeeding, or planning pregnancy during the study
  • Other reasons making the participant unsuitable at investigator's discretion

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Wisconsin

Madison, Wisconsin, United States, 53702

Actively Recruiting

Loading map...

Research Team

H

Hayley Mann, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here